Direkt zum InhaltDirekt zur SucheDirekt zur Navigation
▼ Zielgruppen ▼

IRI Life Sciences

Humboldt-Universität zu Berlin | IRI Life Sciences | News | Chris Sander is Einstein BIH Visiting Fellow at IRI Life Sciences

Chris Sander is Einstein BIH Visiting Fellow at IRI Life Sciences

The Einstein BIH Visiting Fellow - program temporarily invites leading personalities from universities abroad to Berlin to set up working groups on current life science research topics.

One of the newly awarded Einstein BIH Visiting Fellows is Professor Dr. Chris Sander. Chris Sander is Professor of Cell Biology at Harvard Medical School (USA), a world leader in computer-assisted cancer research and one of the founders of perturbation biology - a field that seeks to predict the responses of cells to certain disorders using computer simulations.

His new working group in Berlin will take advantage of the possibilities of new methods of single-cell analysis over the next few years in order to be able to estimate and individually improve the effectiveness of drugs in the treatment of different tumors. For this purpose, among other things, organoids from tissue samples of cancer patients are generated and their treatment options are analyzed down to the level of single cells and simulated.

He will be hosted in the group of IRI-Professor Nils Blüthgen from the Department of Pathology at Charité and IRI Life Sciences and on the part of the Max Delbrück Center for Molecular Medicine, IRI-Professor Markus Landthaler.